Demand for Antibiotic may alter U.S patent policies
The U.S government's response to demand for Cipro, an antibiotic for treating anthrax, could open the floodgated for poor countries that want to bypass international patent agreements and import
The U.S government's response to demand for Cipro, an antibiotic for treating anthrax, could open the floodgated for poor countries that want to bypass international patent agreements and import